ストックスクリーナーアプリを入手
7.44
3.33%
0.24
アフターアワーズ：
7.25
-0.19
-2.55%
前日終値:
$7.20
開ける：
$7.2
24時間の取引高:
48,869
Relative Volume:
0.45
時価総額：
$48.01M
収益：
$5.75M
当期純損益:
$-38.96M
株価収益率:
-0.5966
EPS:
-12.47
ネットキャッシュフロー:
$-32.63M
1週間 パフォーマンス:
-3.38%
1か月 パフォーマンス:
+27.18%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+25.99%
1日の値動き範囲:
$7.20
$7.814
1週間の範囲:
$7.00
$7.92
52週間の値動き範囲:
$2.92
$11.20
Kala Bio Inc Stock (KALA) Company Profile
KALA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
7.44 | 46.46M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-11 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-03-30 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-09-14 | ダウングレード | Jefferies | Buy → Hold |
| 2020-07-23 | 開始されました | Northland Capital | Outperform |
| 2020-06-01 | 再開されました | Oppenheimer | Outperform |
| 2020-05-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-09 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | 開始されました | Jefferies | Buy |
すべてを表示
Kala Bio Inc (KALA) 最新ニュース
Is KALA BIO Inc. showing insider buyingROIC-Focused Investment List - thegnnews.com
Why KALA BIO Inc. stock attracts strong analyst attentionMachine Learning Stock Movement Detector - Newser
How KALA BIO Inc. stock performs during market volatilityShort-Term Market Movement Forecast Report - Newser
Technical analysis overview for KALA BIO Inc. stockPrice Movement and Market Sentiment Analysis - Newser
Using portfolio simulators with KALA BIO Inc. includedFree Swing Setup With Technical Confirmation - Newser
What makes KALA BIO Inc. stock price move sharplyFree Risk Managed Intraday Trade Alerts - Newser
Can volume confirm reversal in KALA BIO Inc.Free AI Screening for Swing Trade Picks - Newser
Is KALA BIO Inc. a Top Dividend Stock to Watch in 2025Profitable Trading Blueprint with Entry Zones - Newser
Trend analysis for KALA BIO Inc. this weekWeekly Trend Watch with Market Signals - Newser
What drives KALA BIO Inc.’s stock priceStocks with 300% Upside - sisaissue.com
KALA BIO Inc. stock trend forecastEntry Opportunity Screener with Confirmation - Newser
Comparing KALA BIO Inc. in custom built stock radarsWatchlist Generator With Real-Time Entry - Newser
KALA BIO: Q2 Earnings Snapshot - Greenwich Time
KALA BIO (NASDAQ:KALA) Stock Rating Lowered by Wall Street Zen - Defense World
Can KALA BIO Inc. recover in the next quarterFree Community Entry Consensus Trade Ideas - Newser
Momentum divergence signals in KALA BIO Inc. chartShort-Term Profit Alert With Entry Forecast - Newser
Kala Bio (KALA) Q2 Loss Widens 15% - AOL.com
KALA BIO Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biotech's Long Game: Assessing KALA BIO's Q2 Loss in the Context of Strategic Innovation - AInvest
Kala Bio (KALA) Q2 Loss Widens 15% - The Motley Fool
KALA BIO, Inc. Completes Patient Enrollment in Phase 2b CHASE Trial for KPI-012 in Persistent Corneal Epithelial Defect, Reports Financial Results and Upcoming Milestones - Quiver Quantitative
KALA BIO, Inc. SEC 10-Q Report - TradingView
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference | KALA Stock News - GuruFocus
KALA BIO, Inc. to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference on August 13, 2025 - Quiver Quantitative
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewswire
What candlestick patterns are forming on KALA BIO Inc.Machine Learning Stock Price Forecast Tool - Newser
KALA BIO Inc. Company’s Quarterly Earnings Growth: What the Numbers SayDownside Risk Evaluation and Stock Analysis - Newser
What is the dividend policy of KALA BIO Inc. stockUnlock market-leading stock analysis - Jammu Links News
Should I hold or sell KALA BIO Inc. stock in 2025Capitalize on strategic market trends - Jammu Links News
How volatile is KALA BIO Inc. stock compared to the marketRapid growth opportunities - Jammu Links News
Is KALA BIO Inc. stock overvalued or undervaluedAchieve consistent double-digit growth rates - Jammu Links News
What institutional investors are buying KALA BIO Inc. stockCapitalize on proven investment strategies - Jammu Links News
How does KALA BIO Inc. compare to its industry peersOutstanding capital returns - Jammu Links News
Is KALA BIO Inc. a growth stock or a value stockAchieve exceptional returns with expert guidance - Jammu Links News
Kala Bio Inc (KALA) 財務データ
収益
当期純利益
現金流量
EPS
0.91%
3.06%
大文字化:
|
ボリューム (24 時間):